Qin-Wen Liu
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Qin-Wen Liu has a total of 33 co-authors. Here are the top co-authors by number of shared publications:
- Bin Li
State Key Laboratory of Respiratory Disease, Key Laboratory of Biological Targeting Diagnosis, Therapy and Rehabilitation of Guangdong Higher Education Institutes, the Fifth Affiliated Hospital, Guangzhou Medical University, Guangzhou, China
102 shared publications - Chun-Miao Deng
Key Laboratory of Biological Targeting Diagnosis, Therapy and Rehabilitation of Guangdong Higher Education Institutes, State Key Laboratory of Respiratory Disease, The Fifth Affiliated Hospital of Guangzhou Medical University, Guangzhou, China
102 shared publications - Fan Zhang
The Key Laboratory of Biological Targeting Diagnosis, Therapy and Rehabilitation of Guangdong Higher Education Institutes The Fifth Affiliated Hospital of Guangzhou Medical University, Guangzhou Medical University Guangzhou China
102 shared publications - Guo-Geng Zhang
Key Laboratory of Biological Targeting Diagnosis, Therapy and Rehabilitation of Guangdong Higher Education Institutes, State Key Laboratory of Respiratory Disease, The Fifth Affiliated Hospital of Guangzhou Medical University, Guangzhou, China
102 shared publications - Jiao-Jiao Xu
Guangzhou Medical University 1 Guangdong Provincial Key Laboratory of Protein Modification and Degradation, School of Basic Medical Sciences, The Affiliated Traditional Chinese Medicine Hospital, The Fifth Affiliated Hospital Guangzhou, China
102 shared publications - Jing Yang
Guangzhou Medical University 1 Guangdong Provincial Key Laboratory of Protein Modification and Degradation, School of Basic Medical Sciences, The Affiliated Traditional Chinese Medicine Hospital, The Fifth Affiliated Hospital Guangzhou, China
102 shared publications
Latest Publications
- Open Access
- 4 November 2026
- Published by Elsevier in Materials & Design
- Vol. 272
Asiatic acid-based injectable nanohydrogel attenuates osteoarthritis by disrupting CCL17-associated macrophage–chondrocyte crosstalk
- 4 November 2026
- Published by Elsevier in Materials & Design
- Vol. 272
Open AccessAsiatic acid-based injectable nanohydrogel attenuates osteoarthritis by disrupting CCL17-associated macrophage–chondrocyte crosstalk
- Open Access
- 24 November 2025
- Published by American Association for Cancer Research (AACR)
Supplementary Methods from ANO1 Reprograms Cholesterol Metabolism and the Tumor Microenvironment to Promote Cancer Metastasis
Supplementary Methods shows supplementary Materials and Methods
- 24 November 2025
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Methods from ANO1 Reprograms Cholesterol Metabolism and the Tumor Microenvironment to Promote Cancer Metastasis
Supplementary Methods shows supplementary Materials and Methods
- Open Access
- 24 November 2025
- Published by American Association for Cancer Research (AACR)
Supplementary Table 8 from ANO1 Reprograms Cholesterol Metabolism and the Tumor Microenvironment to Promote Cancer Metastasis
Supplementary Table 8 shows Cytokines upregulated in the CM from ANO1 overexpressing EC9706 cells compared with control cells
- 24 November 2025
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Table 8 from ANO1 Reprograms Cholesterol Metabolism and the Tumor Microenvironment to Promote Cancer Metastasis
Supplementary Table 8 shows Cytokines upregulated in the CM from ANO1 overexpressing EC9706 cells compared with control cells
- Open Access
- 24 November 2025
- Published by American Association for Cancer Research (AACR)
Supplementary Table 2 from ANO1 Reprograms Cholesterol Metabolism and the Tumor Microenvironment to Promote Cancer Metastasis
Supplementary Table 2 shows qRT-PCR primers
- 24 November 2025
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Table 2 from ANO1 Reprograms Cholesterol Metabolism and the Tumor Microenvironment to Promote Cancer Metastasis
Supplementary Table 2 shows qRT-PCR primers
- Open Access
- 24 November 2025
- Published by American Association for Cancer Research (AACR)
Supplementary Table 4 from ANO1 Reprograms Cholesterol Metabolism and the Tumor Microenvironment to Promote Cancer Metastasis
Supplementary Table 4 shows DEGs between highly metastasis ESCC sub cell line KYSE150-Luc-LM3 and the parental cell line
- 24 November 2025
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Table 4 from ANO1 Reprograms Cholesterol Metabolism and the Tumor Microenvironment to Promote Cancer Metastasis
Supplementary Table 4 shows DEGs between highly metastasis ESCC sub cell line KYSE150-Luc-LM3 and the parental cell line
- Open Access
- 24 November 2025
- Published by American Association for Cancer Research (AACR)
Supplementary Table 9 from ANO1 Reprograms Cholesterol Metabolism and the Tumor Microenvironment to Promote Cancer Metastasis
Supplementary Table 9 shows Top 30 cytokines upregulated in the CM from fibroblasts cultured with CM-ANO1 compared with CM-CON
- 24 November 2025
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Table 9 from ANO1 Reprograms Cholesterol Metabolism and the Tumor Microenvironment to Promote Cancer Metastasis
Supplementary Table 9 shows Top 30 cytokines upregulated in the CM from fibroblasts cultured with CM-ANO1 compared with CM-CON
- Open Access
- 24 November 2025
- Published by American Association for Cancer Research (AACR)
Supplementary Table 5 from ANO1 Reprograms Cholesterol Metabolism and the Tumor Microenvironment to Promote Cancer Metastasis
Supplementary Table 5 shows Correlation between ANO1 expression levels and clinicopathological parameters in 100 cases of esophageal cancer
- 24 November 2025
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Table 5 from ANO1 Reprograms Cholesterol Metabolism and the Tumor Microenvironment to Promote Cancer Metastasis
Supplementary Table 5 shows Correlation between ANO1 expression levels and clinicopathological parameters in 100 cases of esophageal cancer
- Open Access
- 24 November 2025
- Published by American Association for Cancer Research (AACR)
Supplementary figure from ANO1 Reprograms Cholesterol Metabolism and the Tumor Microenvironment to Promote Cancer Metastasis
Supplementary figures shows Supplementary figures and figure legends
- 24 November 2025
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary figure from ANO1 Reprograms Cholesterol Metabolism and the Tumor Microenvironment to Promote Cancer Metastasis
Supplementary figures shows Supplementary figures and figure legends
- Open Access
- 24 November 2025
- Published by American Association for Cancer Research (AACR)
Supplementary Table 6 from ANO1 Reprograms Cholesterol Metabolism and the Tumor Microenvironment to Promote Cancer Metastasis
Supplementary Table 6 shows DEGs of EC9706 overexpressing ANO1 and control cells
- 24 November 2025
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Table 6 from ANO1 Reprograms Cholesterol Metabolism and the Tumor Microenvironment to Promote Cancer Metastasis
Supplementary Table 6 shows DEGs of EC9706 overexpressing ANO1 and control cells
- Open Access
- 24 November 2025
- Published by American Association for Cancer Research (AACR)
Supplementary Table 3 from ANO1 Reprograms Cholesterol Metabolism and the Tumor Microenvironment to Promote Cancer Metastasis
Supplementary Table 3 shows DEGs between ESCC primary tumors and matched lymph node metastatic tumors
- 24 November 2025
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Table 3 from ANO1 Reprograms Cholesterol Metabolism and the Tumor Microenvironment to Promote Cancer Metastasis
Supplementary Table 3 shows DEGs between ESCC primary tumors and matched lymph node metastatic tumors